DIAZACARBAZOLES AND METHODS OF APPLICATION Russian patent published in 2014 - IPC C07D471/14 A61K31/437 A61P35/00 

Abstract RU 2515972 C2

FIELD: chemistry.

SUBSTANCE: invention relates to 1.7-diazacarbazole compounds of formula (I) or to its solvates, hydrates or salts , where X, Y, Z, R3, R5 and R6 are such as given in i.1 of the invention formula. In addition, invention relates to pharmaceutical composition, containing formula (I) compounds, which possesses inhibiting activity with respect to kinase of control point 1 (chk1).

EFFECT: novel compounds, which can be useful as kinase inhibitors and therefore are useful as anticancer therapeutic medications, are obtained and described.

26 cl, 403 ex, 16 tbl

Similar patents RU2515972C2

Title Year Author Number
DERIVATIVE 6-CARBONITRILE DIPYRIDOPYRROLES AND APPLICATION THEREOF IN CANCER TREATMENT 2010
  • Chehn' Khuehjfehn'
  • Drobnik Dzhoj
  • Dajk Khejzl Dzhoan
  • Ehllvud Charl'Z
  • Gazzard L'Juis Dzh.
  • Gudakr Sajmon
  • Kintts Sehmjuel'
  • Lissikatos Dzhozef P.
  • Makleod Kalum
  • Uill'Jams Karen
RU2575635C2
SUBSTITUTED PYRROLES ACTIVE AS KINASES INHIBITORS 2013
  • Braska Mariya Gabriella
  • Bindi Simona
  • Kaldarelli Marina
  • Nezi Marchella
  • Orrenius Sten Kristian
  • Pantseri Akille
RU2666538C2
TRICYCLIC PYRROLE DERIVATIVES, METHOD FOR PRODUCTION THEREOF AND USE THEREOF AS KINASE INHIBITORS 2012
  • Kaldarelli Marina
  • Andzholini Mauro
  • Beriya Italo
  • Braska Mariya Gabriella
  • Kazushelli Franchesko
  • D'Alessio Roberto
  • Lombardi Bordzhia Andrea
RU2591191C2
PYRAZOLE COMPOUNDS AS MODULATORS OF FSHR AND USES THEREOF 2014
  • Yuj Genri
  • Donnelli Merien
  • Ngujen Ngan
  • Tszyan Syujlyan
RU2663898C2
HETEROCYCLIC COMPOUNDS AND METHODS OF THEIR USE 2012
  • Khadd Majkl Dzh.
  • Khoker Majkl D.
  • Kholladej Mark U.
  • Lyu Gan
  • Roubottom Martin U.
  • Syuj Shimin
RU2648997C2
HETEROCYCLIC COMPOUNDS USEFUL AS PDK1 INHIBITORS 2010
  • Arndt Dzhozef
  • Chan Timoti
  • Gukian Kevin
  • Kumaravel Gianasambandam
  • Li Ven-Cherng
  • Lin Edvard In-Shian
  • Skott Deniel
  • Sun Likhun
  • Tomas Dzhermejn
  • Van Vloten Kurt
  • Van Depin
  • Chzhan Lej
  • Erlanson Deniel
RU2615130C2
AZALACTAM COMPOUNDS AS HPK1 INHIBITORS 2019
  • Gallego, Rebekka Enn
  • Nair, Sadzhiv Krishnan
  • Kania, Robert Stiven
  • Akhmad, Omar Kkhaled
  • Dzhonson, Ted Uillyam
  • Tattl, Dzhejmison Brajs
  • Dzhalej, Mekhran
  • Maktig, Mishel Enn
  • Chzhou, Dakhuej
  • Del Bel, Mettyu L.
  • Chzhou, Ru
  • Khe, Mining
  • Shmitt, Anne-Mari Dechert
RU2801140C2
RMT5 INHIBITORS 2019
  • Mashasek, Mishell
  • Vitter, Devid
  • Zhibo, Krejg
  • Khuan, Chunkhoj
  • Kavamura, Sukhei
  • Sloman, Devid, L.
  • Silipkhaivankh, Pkhieng
  • Kiros, Rajan
  • Van, Myurrej
  • Shnajder, Sebastyan
  • Jeung, Charlz, S.
  • Rojtershan, Majkl, Kh.
  • Khenderson, Timoti, Dzh.
  • Paparen, Zhan-Loran
  • Raali, Usin
  • Khyuz, Dzhonatan, M., E.
  • Sanyal, Sulagna
  • Je, Jingchun
  • Kandito, Devid, A.
  • Fajer, Patrik, S.
  • Silverman, Stiven, M.
RU2814198C2
MODULATORS OF NUCLEAR RECEPTORS 2016
  • Argiriadi, Maria, A.
  • Breinlinger, Eric, C.
  • Cusack, Kevin, P.
  • Hobson, Adrian, D.
  • Potin, Dominique
  • Barth, Martine
  • Amaudrut, Jerome
  • Poupardin, Olivia
  • Mounier, Laurent
  • Kort, Michael, E.
RU2715897C2
POLYCYCLIC ANTAGONISTS OF TLR7/8 AND THEIR USE IN TREATMENT OF IMMUNE DISORDERS 2016
  • Sherer, Brajan A.
  • Brugger, Nadya
RU2783748C2

RU 2 515 972 C2

Authors

Dajk Khejzel Dzhoan

Ehllvud Charl'Z

Gansia Ehmanuehla

Gazzard L'Juis Dzh.

Gudehjkr Sajmon Charl'Z

Kintz Samuehl' S.

Lissikatos Dzhozef P.

Makleod Kalum

Uill'Jams Karen

Dates

2014-05-20Published

2009-06-10Filed